For research use only
| Cat No. | ABC-SC2051 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | B-Lymphocyte |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Cell Type: iPSC; Disease: Personal Genome Project.
HighQC™ Human IPSC From B-Lymphocyte-Personal Genome Project is a human induced pluripotent stem cell line generated from B-lymphocytes isolated from the peripheral blood mononuclear cells (PBMCs) of a healthy donor participating in the Personal Genome Project. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. These cells possess the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. They express the core pluripotency marker SSEA-4 and retain B-lymphocyte-derived traits and reflect in vivo immune system physiology. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From B-Lymphocyte-Personal Genome Project, HighQC™ hiPSC PGP, hiPSC-PGP, HighQC™ Human Induced Pluripotent Stem Cells From B-Lymphocyte-Personal Genome Project |
| Species | Human |
| Cat.No | ABC-SC2051 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | B-Lymphocyte |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human IPSC From B-Lymphocyte-Personal Genome Project serves as a genetically defined baseline for in vitro developmental and comparative studies. Its pluripotent capacity supports differentiation into diverse lineages, including hematopoietic progenitors, neurons, and cardiomyocytes. This cell line is particularly valuable as a normal control for gene editing, disease mechanism studies, organoid development, and functional validation in comparison to patient-specific disease models.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).